MBX - רווח נקי למניה (EPS TTM) MBX Biosciences

A lack of profitability and a dependence on investment define the financial profile of MBX Biosciences Inc (MBX). This 12-month EPS chart demonstrates a historical peak, with the -3.07 level representing the current value. MBX Biosciences Inc (MBX) attracts leading endocrinologists through stock options and research freedom. Currently, the R&D center is preparing Phase 2 data on peptide-based treatments for metabolic disorders.

For MBX Biosciences Inc (MBX), the specific annual income indicator reflects the net earnings per share over a rolling twelve-month period, allowing the company to filter out speculative noise from actual business growth. This metric assesses the efficiency of capitalizing scientific developments in endocrine peptides, demonstrating how strong R&D potential and regulatory compliance translate into actual returns for each shareholder.